Clik here to view.
STENTYS Expands Marketing of its Stents in Asia
PRINCETON, N.J. & PARIS STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® Stent for treating acute myocardial infarction...
View ArticleClik here to view.
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement...
SHANGHAI & MILAN MicroPort Scientific Corporation (HK: 00853) and Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), announced today that they have entered into a definitive agreement to form a...
View ArticleClik here to view.
有关KCI负压伤口滴注疗法的首篇国际共识指南发表
圣安东尼奥 (美国商业资讯)–Kinetic Concepts, Inc. (KCI)今天宣布，有关该公司负压伤口滴注疗法(NPWTi)的首篇国际共识指南发表。 1 该指南发表于《整形及整复外科杂志》12月刊上。 KCI首席医学官Ron...
View ArticleClik here to view.
Akorn Acquires Betimol® from Santen
LAKE FOREST, Ill. Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced that it has acquired the NDA and all rights to Betimol® (timolol ophthalmic solution) 0.25%...
View ArticleClik here to view.
エリテックがリードプロダクトを固形腫瘍向けに展開し、すい臓がんの第II相臨床研究を開始
仏リヨン （ビジネスワイヤ） — Regulatory News: 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
KCIの洗浄併用陰圧創傷治療に関し、初の国際コンセンサスガイドラインが公刊される
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツ（KCI）は本日、当社の洗浄併用陰圧創傷治療（NPWTi）に関する初の国際コンセンサスガイドライン1を公刊したと発表しました。本ガイドラインは、Journal of Plastic and Reconstructive Surgery誌12月号に掲載されています。...
View ArticleClik here to view.
Semler Research Center US Appoints Dr Nuggehally Srinivas as the President of...
AGOURA HILLS, Calif. Semler Research Center US (SRC US) has announced its formation of a new business unit within Arnold A Semler Inc, which also owns SRC India, and the appointment of Dr Nuggehally...
View ArticleClik here to view.
pSivida Corp. Reports First Orders for ILUVIEN® Shipped for U.K. National...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View ArticleClik here to view.
Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection...
Smart Multimedia Gallery ViaFect(TM) Transfection Reagent offers high performance transfection in a diversity of cell lines and iPSC-derived tissue cells. (Photo: Business Wire) View and Share Photo...
View ArticleClik here to view.
エリテックがAMLにおける欧州での第 IIb相試験につき、フィンランドとスペインで臨床試験実施許可を取得と発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（NYSE Euronext Paris: FR0011471135 – ERYP）は、フィンランドとスペインで急性骨髄性白血病（AML）における第...
View ArticleClik here to view.
KCI负压伤口疗法伴滴注增刊发表于国际伤口杂志
圣安东尼奥 (美国商业资讯)–Kinetic Concepts, Inc.今天宣布，《国际伤口杂志》(IWJ)近期发布了一份增刊，该增刊总结了伤口治疗的现有挑战和实践，呈报了V.A.C. VeraFlo™滴注疗法(NPWTi)用于污染或复杂伤口清洗和治疗的证据和临床经验。该增刊基于2012年和2013年国际外科伤口论坛上的呈报，这些论坛揭示了现代伤口治疗挑战和技术方面的专家研究。...
View ArticleClik here to view.
KCIの洗浄併用陰圧創傷治療を扱ったInternational Wound Journal誌特集号が発行
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツ（KCI）は本日、International Wound Journal（IWJ）誌の特集号がこのほど発行されたと発表しました。この特集号は現在の創傷ケアの課題と実践について要点を述べ、汚染創または複雑な創傷の洗浄と治療のためのV.A.C. VeraFlo™ Instillation...
View ArticleClik here to view.
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan...
BOTHELL, Wash. Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval of ADCETRIS (brentuximab vedotin)...
View ArticleClik here to view.
Terumo BCT Exclusive Therakos Inc. Distributor
LAKEWOOD, Colo. Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Therakos, Inc., a global leader in...
View ArticleClik here to view.
Menicon Realizes Bold Vision in the Netherlands
Smart Multimedia Gallery Emmen Mayor Cees Bijl, Menicon CEO Hidenari Tanaka and Japanese diplomat Yutaka Kikuta cut the ceremonial ribbon to open Menicon’s new facility at Emmen, the Netherlands....
View ArticleClik here to view.
Biocon Collaborates with Advaxis for ‘ADXS-HPV’ A Novel Cancer Immunotherapy
BANGALORE, India & PRINCETON, N.J. Biocon Ltd., (BIOCON.BO), Asia’s premier biotechnology company, and Advaxis, Inc., (NASDAQ: ADXS), a leader in developing the next generation of cancer...
View ArticleClik here to view.
Starpharma Commences Dendrimer-Docetaxel Clinical Trial
MELBOURNE, Australia Starpharma (ASX:SPL)(OTCQX:SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human clinical trial for its dendrimer-enhanced docetaxel...
View ArticleClik here to view.
Menicon在荷兰实现重大愿景
Smart Multimedia Gallery Emmen Mayor Cees Bijl, Menicon CEO Hidenari Tanaka and Japanese diplomat Yutaka Kikuta cut the ceremonial ribbon to open Menicon’s new facility at Emmen, the Netherlands....
View ArticleClik here to view.
Covidien Launches Advanced Medical Training and Education Center in India
MUMBAI, India Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in India. The Covidien Center of...
View ArticleClik here to view.
蓝十字蓝盾协会总裁兼首席执行官将在WIN2014研讨会上致开幕词
巴黎 (美国商业资讯)–WIN联合会(www.winconsortium.org)今日非常荣幸地宣布，蓝十字蓝盾协会(Blue Cross and Blue Shield Association, BCBSA)总裁兼首席执行官Scott P. Serota将在个体化抗癌医学领域中的WIN...
View Article